tiprankstipranks
Advertisement
Advertisement
Kelun-Biotech Wins China IND Approval for Bispecific Cancer Antibody SKB118
PremiumCompany AnnouncementsKelun-Biotech Wins China IND Approval for Bispecific Cancer Antibody SKB118
2M ago
Kelun-Biotech’s sac-TMT Wins Priority Review for New Lung Cancer Use in China
Premium
Company Announcements
Kelun-Biotech’s sac-TMT Wins Priority Review for New Lung Cancer Use in China
2M ago
Sichuan Kelun-Biotech Completes H Share Full Circulation Conversion
Premium
Company Announcements
Sichuan Kelun-Biotech Completes H Share Full Circulation Conversion
2M ago
Kelun-Biotech: Transitioning to Commercial Growth with sac-TMT as a Key Value Driver Supporting a Sustained Buy Rating
PremiumRatingsKelun-Biotech: Transitioning to Commercial Growth with sac-TMT as a Key Value Driver Supporting a Sustained Buy Rating
3M ago
Kelun-Biotech Wins NMPA Green Light to Begin Trials of Novel Bispecific ADC SKB103
Premium
Company Announcements
Kelun-Biotech Wins NMPA Green Light to Begin Trials of Novel Bispecific ADC SKB103
3M ago
Kelun-Biotech Widens Losses as It Accelerates ADC Push and Wins New China Approvals
Premium
Company Announcements
Kelun-Biotech Widens Losses as It Accelerates ADC Push and Wins New China Approvals
3M ago
Kelun-Biotech Wins Fourth China Indication for Core TROP2 ADC in Advanced Breast Cancer
PremiumCompany AnnouncementsKelun-Biotech Wins Fourth China Indication for Core TROP2 ADC in Advanced Breast Cancer
5M ago
Kelun-Biotech Details Pricing Controls for 2026 Connected R&D Procurement
Premium
Company Announcements
Kelun-Biotech Details Pricing Controls for 2026 Connected R&D Procurement
5M ago
Kelun-Biotech Signs New Connected R&D Goods Supply Deal With China Resources Kelun
Premium
Company Announcements
Kelun-Biotech Signs New Connected R&D Goods Supply Deal With China Resources Kelun
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100